Pharma: Novartis shares dropped 9% following three setbacks in drug trials.
Novartis shares plummeted on Tuesday following disappointing results from its del-desiran drug trial, leaving investors concerned. What's next for the pharma giant? #Novartis #PharmaNews
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0